Menarini in the forefront for World Asthma Day

Menarini Group has a long-standing commitment to supporting patients with asthma and

has played a key role in raising awareness about the condition and its associated risks, as well as in promoting preventive measures.

In keeping with this, on May 7th, Menarini will be celebrating World Asthma Day, promoted by the Global Initiative for Asthma (GINA), further reinforcing the company’s pledge to help asthmatic patients.

Through its comprehensive portfolio of respiratory medications, Menarini strives to provide

patients with effective treatment options tailored to their needs. Moreover, the Menarini Group is actively involved in initiatives aimed at educating healthcare professionals, patients, and the public about asthma management, including the importance of early diagnosis, personalized treatment approaches, and adherence to therapy.

In addition to its commitment to innovation and education, the Menarini Group recognizes the importance of advocacy and collaboration in addressing the multifaceted challenges of

asthma. By partnering with patient advocacy organizations, healthcare providers,

policymakers, and other stakeholders, Menarini seeks to amplify its impact and drive meaningful change in the respiratory healthcare landscape.

People are at the heart of Menarini’s values, such as people care and patient focus.

In celebration of World Asthma Day 2024, the Global Initiative for Asthma (GINA) has selected the theme of “Asthma Education Empowers”. GINA emphasizes the need to empower people with asthma with the appropriate education to manage their disease, and to recognize when to seek medical help. Health care professionals are called upon to increase their awareness of the continuing avoidable morbidity and mortality from asthma, and the published evidence on effective management of asthma, so they are equipped to provide reliable information and optimal treatment for their patients. (1)

Asthma is one of the most common chronic non-communicable diseases that affects over

260 million people and is responsible for over 450000 deaths each year worldwide, most

of which are preventable. (1)

Asthma education is fundamental for successful disease management. When patients fully understand their condition, its triggers, and appropriate treatment strategies, they become active participants in their own care. This empowerment leads to better adherence to

medication regimens, proactive avoidance of triggers, and early recognition of worsening

symptoms. As a result, the risk of severe asthma attacks and hospitalizations can be

greatly reduced. (2)

Menarini’s mission is a cure for every disease. More health, more happiness and more life.

 

#menarinigroup #menarini #wearemenarini #worldasthmaday #ginasthma

https://www.menarini.com/en-us/

https://ginasthma.org/world-asthma-day-may-7-2024/

 

 

 

 

References

  1. https://ginasthma.org/world-asthma-day-2024/
  2. Pinnock H, Parke HL, Panagioti M, et al. Systematic review of supported self management for asthma: a healthcare perspective. BMC Medicine. 2017; 15:64.